Form 8-K - Current report:
SEC Accession No. 0000320017-25-000048
Filing Date
2025-07-15
Accepted
2025-07-15 08:00:44
Documents
17
Period of Report
2025-07-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K clbs-20250715.htm   iXBRL 8-K 24418
2 EX-99.1 ex991certepetidepatentpr20.htm EX-99.1 15018
3 EX-99.2 ex992patent.htm EX-99.2 4680
7 ex992patent001.jpg GRAPHIC 71794
8 ex992patent002.jpg GRAPHIC 165841
9 ex992patent003.jpg GRAPHIC 153359
  Complete submission text file 0000320017-25-000048.txt   710222

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT clbs-20250715.xsd EX-101.SCH 1776
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT clbs-20250715_lab.xml EX-101.LAB 22804
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT clbs-20250715_pre.xml EX-101.PRE 13042
19 EXTRACTED XBRL INSTANCE DOCUMENT clbs-20250715_htm.xml XML 2825
Mailing Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920 908-229-2590
LISATA THERAPEUTICS, INC. (Filer) CIK: 0000320017 (see all company filings)

EIN.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33650 | Film No.: 251123130
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)